|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$187,779,289 |
|
|
Indirect Value
|
$47,355,030 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$235,134,319 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-11-01 |
4 |
AS |
$75.08 |
$5,509,697 |
D/D |
(73,333) |
2,996,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-12-01 |
4 |
AS |
$74.35 |
$5,498,385 |
D/D |
(73,333) |
2,996,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-12-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,070,099 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-01-02 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,046,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-01-02 |
4 |
AS |
$72.26 |
$3,681,235 |
D/D |
(50,000) |
2,996,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-01 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,046,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-01 |
4 |
AS |
$83.35 |
$4,177,824 |
D/D |
(50,000) |
2,996,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
2,997,106 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
40,010 |
3,037,116 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-21 |
4 |
D |
$80.69 |
$1,561,674 |
D/D |
(19,354) |
3,017,762 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-03-01 |
4 |
AS |
$77.84 |
$3,932,375 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-03-01 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
officerTitle |
|
2003-08-08 |
4 |
OE |
$3.50 |
$238,750 |
D/D |
50,000 |
340,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
officerTitle |
|
2003-08-08 |
4 |
S |
$62.28 |
$3,136,075 |
D/D |
(50,000) |
310,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
officerTitle |
|
2005-12-21 |
4 |
OE |
$2.86 |
$139,686 |
D/D |
44,640 |
728,217 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2003-11-04 |
4 |
OE |
$5.63 |
$225,000 |
D/D |
40,000 |
350,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2003-11-04 |
4 |
S |
$54.56 |
$2,199,895 |
D/D |
(40,000) |
310,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2003-12-24 |
4 |
OE |
$6.53 |
$97,970 |
D/D |
15,000 |
325,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-02-05 |
4 |
S |
$56.49 |
$1,130,900 |
D/D |
(20,000) |
345,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-02-06 |
4 |
S |
$56.40 |
$1,694,600 |
D/D |
(30,000) |
335,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-02-06 |
4 |
OE |
$5.63 |
$346,563 |
D/D |
60,000 |
385,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-05-03 |
4 |
OE |
$5.63 |
$225,000 |
D/D |
40,000 |
339,290 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-05-03 |
4 |
S |
$60.46 |
$2,429,290 |
D/D |
(40,000) |
335,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-05-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
332,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-08-04 |
4 |
S |
$62.75 |
$3,805,050 |
D/D |
(60,000) |
332,790 |
|
- |
|
367 Records found
|
|
Page 12 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|